A carregar...

A Novel Targeted Inhibitor of the Alternative Pathway of Complement and Its Therapeutic Application in Ischemia/Reperfusion Injury

Bioavailability and therapeutic efficacy of soluble Crry, a mouse inhibitor of all complement activation pathways, is significantly enhanced when linked to a fragment of complement receptor 2 (CR2), a receptor that targets C3 activation products. In this study, we characterize alternative pathway-sp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Huang, Yuxiang, Qiao, Fei, Atkinson, Carl, Holers, V. Michael, Tomlinson, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2782395/
https://ncbi.nlm.nih.gov/pubmed/19017999
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!